Rights to Publish Sample Clauses

The 'Rights to Publish' clause defines the permissions and limitations regarding the publication of information, data, or results generated under an agreement. Typically, it outlines which party has the right to publish, any required approvals or review periods, and the process for handling confidential or proprietary information before public disclosure. For example, a research institution may need to provide advance notice to a corporate sponsor before publishing study results, allowing the sponsor to review for sensitive content. This clause ensures that both parties' interests are protected by balancing the need for academic or public dissemination with the protection of confidential or commercially valuable information.
POPULAR SAMPLE Copied 3 times
Rights to Publish. UWMRF (on behalf of itself, the University and the Inventor) and Company reserves their rights to release or publish, either written or orally, the results of research related to the Licensed Subject Matter, to the scientific and business community in scientific journals or at any industry, investment, field, trade, business, scientific or technical conference, seminar, symposia or similar event, so long as such publication does not conflict with the other provisions of this Article 12. Without limiting the generality of the foregoing, Company shall be entitled to present, publish and release the results of its scientific work and development efforts without notification to or consent from UWMRF. In the event UWMRF or University (or any of their respective faculty, employee(s) or students) desires to publish the results of research related to the Licensed Subject Matter, such party shall give Company no less than sixty (60) days prior to the submission for publication a copy of the proposed publication (or an outline of such oral disclosure) to review the proposed publication and provide UWMRF with its comments and suggested changes. UWMRF shall take such comments and suggested changes reasonably into account. Within this sixty (60) day period the Company may request UWMRF, in writing, to delay such submission for publication or oral disclosure for a maximum of an additional thirty (30) days in order to protect the potential patentability of any invention described therein, and UWMRF shall comply with any such request so long as it is reasonable and cooperate with Company towards that end. Such delay must not, however, be imposed on the filing of any student thesis or dissertation by way of this Article 12.
View SourceView Similar (3)
Rights to Publish. At the University’s request, inventors shall delay the publication or public disclosure of any descriptions of technology for a brief period of time to permit the registration, application for, and protection of the intellectual property UNIVERSITY OF MINNESOTA BOARD OF REGENTS POLICY Academic COMMERCIALIZATION OF INTELLECTUAL PROPERTY RIGHTS Adopted: December 14, 2007 Amended: December 10, 2010, February 14, 2014, June 12, 2015 Page 4 of 6 rights in the technology. Subd.
View SourceView Similar (2)
Rights to Publish. Company shall have the right to publish or publicly present Clinical Data or Sample Analysis Results (other than Clinical Data within Gilead Project IP) at any time; provided, however, that any such publication or presentation by or on behalf of Company shall be made solely in accordance with the provisions of Section 10.2.2. Gilead shall have the right to publish or publicly present Clinical Data or Sample Analysis Results (other than Clinical Data within Company Project IP) at any time after the earlier of (a) Company’s first publication or public presentation of Clinical Data or Sample Analysis Results and (b) the date that is [***] months after Company first provides to Gilead a draft of the final study report for the Gilead Arm pursuant to Section 4.1.4(c); provided, however, that Gilead shall have the right to publish or publicly present any Clinical Data within Gilead Project IP at any time; and provided, further, that any such publication or presentation by or on behalf of Gilead shall be made solely in accordance with the provisions of Section 10.2.2. Notwithstanding the foregoing, (i) Company shall have the right to disclose or present any Clinical Data or Sample Analysis Results (other than Clinical Data within Gilead Project IP), and (ii) Gilead shall have the right to disclose [***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed. or present any Clinical Data or Sample Analysis Results (other than Clinical Data within Company Project IP), in each case ((i) and (ii)), at any time in connection with internal meetings of Company or Gilead, as applicable, or otherwise for internal development purposes so long as all persons receiving such Clinical Data or Sample Analysis Results are employees or contractors of Company or Gilead, as applicable, that are subject to obligations of confidentiality and non-use with respect to such Clinical Data or Sample Analysis Results that are substantially similar to the obligations of confidentiality and non-use of Company or Gilead, as applicable, under this ARTICLE 8 (provided that the duration of such obligations shall be commercially reasonable under the circumstances).
View SourceView Similar (2)
Rights to Publish. 5.1 The data and information accruing from this Agreement may be published by USM in accordance with USM Intellectual Property Policy respecting the same. The Company may be provided with a copy of any proposed publication at least twenty- one (21) days prior to submission for review of patentable items or items deemed confidential as defined in clause 6 herein. The purpose of this clause is to further protect the rights of USM and the Company in the protection of any contemplated publication concerning details of an invention or the Company’s Confidential Information as defined in the clause 6 herein 5.2 If deemed reasonably necessary by USM and/or the Company to protect such interests, any contemplated publication concerning details of an invention, etc, may be withheld until a patent application is filed or other appropriate steps to protect the commercial value have been contemplated. 5.3 Notwithstanding clause 5.2 above, in no event shall any publication be delayed exceeding twelve (12) months from the date the proposed publication is provided to the Company, but such publication shall not include the Company’s Confidential Information as reasonably determined by the Company and communicated to USM within the twenty-one (21) day review period referenced in clause 5.1 above. 5.3 In all publications arising out of this Agreement, USM and/or the Student may acknowledge the contribution and technical support of the Company.
View SourceView Similar (2)
Rights to Publish. 1.1 The Proprietor hereby guarantees that it has full power and authority to enter into this Agreement and grants to the Publisher for the term of three (3) years from the date of publication the exclusive licence to translate, at its own expense, publish and sell the Work in book form in the Slovakian language subject to the following terms and conditions. 1.2 The Proprietor reserves the right to cancel this Agreement should it not be signed by the Publisher and returned to the Proprietor within sixty (60) days from the date of this Agreement. This also applies if the advance payment mentioned in Clause 4 below is delayed by more than a month and this is not settled within one month after written request from the Proprietor. 1.3 Any and all rights not expressly granted to Publisher under this Agreement are exclusively reserved by the Proprietor at the Proprietor’s full and unrestricted disposal.
View Source
Rights to Publish. During the term of this Employment Agreement and thereafter, Employee shall not produce for publication, circulation or production any movies or writing of any kind, including but not limited to articles, books, manuscripts and playwrights about, concerning, discussing, or mentioning Jack ▇▇▇▇▇▇, ▇▇ any person related to Jack ▇▇▇▇▇▇ ▇▇ blood or marriage whether such related person is now or at a later date is deceased. Further, Employee shall not disclose any information to any party, or consult with any person or entity engaged in or making any efforts to publish, circulate or produce any writing, movie or television program of any kind whatsoever including but not limited to an article, book, manuscript, or playwright concerning Jack ▇▇▇▇▇▇, ▇▇ any person related to Jack ▇▇▇▇▇▇ ▇▇ blood or marriage whether such related person is now or at a later date deceased.
View Source
Rights to Publish. During the term of this Employment Agreement and thereafter, Employee shall not produce for publication, circulation or production any movies or writing of any kind, including but not limited to articles, books, manuscripts and screenplays about, concerning, discussing, or mentioning J▇▇▇ ▇. ▇▇▇▇▇▇, or any person related to J▇▇▇ ▇. ▇▇▇▇▇▇ by blood or marriage whether such related person is now or at a later date deceased. Further, Employee shall not disclose any information to any party, or consult with any person or entity engaged in or making any efforts to publish, circulate or produce any writing, movie or television program of any kind whatsoever including but not limited to an article, book, manuscript, or screenplay concerning J▇▇▇ ▇. ▇▇▇▇▇▇, or any person related to J▇▇▇ ▇. ▇▇▇▇▇▇ by blood or marriage whether such related person is now or at a later date deceased.
View Source
Rights to Publish. UWMRF (on behalf of itself, the University and the Inventor) and COMPANY reserves their rights to release or publish, either written or orally, the results of research related to the
View Source

Related to Rights to Publish

  • Rights to Information 为行使本协议下委托权利之目的，受托人有权要求丙方提供相关信息，查阅丙方相关资料，丙方应对此予以充分配合。 For the purpose of this Agreement, the Designee is entitled to request relevant information of Party C and inspect the materials of Party C. Party C shall provide appropriate assistance to the Designee for his/her work.

  • Rights to Intellectual Property This Data Agreement does not give Service Provider any rights, implied or otherwise, to CDI, data, content or intellectual property except as expressly stated in any underlying agreement between the parties. This includes but is not limited to the right to share, sell or trade CDI. The District acknowledges that this agreement does not convey any intellectual property right in any of Service Provider’s materials or content, including any revisions of derivative work or material. Service Provider-owned materials shall remain the property of the Service Provider. All rights, including copyright, trade secrets, patent and intellectual property rights shall remain the sole property of the Service Provider.

  • CFR PART 200 Rights to Inventions If the Federal award meets the definition of “funding agreement” under 37 CFR §401.2 (a) and the recipient or subrecipient wishes to enter into a contract with a small business firm or nonprofit organization regarding the substitution of parties, assignment or performance of experimental, developmental, or research work under that “funding agreement,” the recipient or subrecipient must comply with the requirements of 37 CFR Part 401, “Rights to Inventions Made by Nonprofit Organizations and Small Business Firms Under Government Grants, Contracts and Cooperative Agreements,” and any implementing regulations issued by the awarding agency. Pursuant to the above, when the foregoing applies to ESC Region 8 and TIPS Members, Vendor certifies that during the term of an award resulting from this procurement process, Vendor agrees to comply with all applicable requirements as referenced in the Federal rule above. Does vendor agree? Yes

  • RIGHTS TO INVENTIONS MADE UNDER A CONTRACT OR AGREEMENT. If the federal award meets the definition of “funding agreement” under 37 C.F.R. § 401.2(a) and the recipient or subrecipient wishes to enter into a contract with a small business firm or nonprofit organization regarding the substitution of parties, assignment or performance of experimental, developmental, or research work under that “funding agreement,” the recipient or subrecipient must comply with the requirements of 37 C.F.R. § 401, “Rights to Inventions Made by Nonprofit Organizations and Small Business Firms Under Government Grants, Contracts and Cooperative Agreements,” and any implementing regulations issued by the awarding agency. Supplier certifies that during the term of an award for all contracts by Sourcewell resulting from this procurement process, Supplier must comply with applicable requirements as referenced above.

  • Rights to Inventions Made Under a Contract or Agreement. If the Federal award meets the definition of “funding agreement” under 37 CFR § 401.2 (a) and the recipient or subrecipient wishes to enter into a contract with a small business firm or nonprofit organization regarding the substitution of parties, assignment or performance of experimental, developmental, or research work under that “funding agreement,” the recipient or subrecipient must comply with the requirements of 37 CFR Part 401, “Rights to Inventions Made by Nonprofit Organizations and Small Business Firms Under Government Grants, Contracts and Cooperative Agreements,” and any implementing regulations issued by the awarding agency.